AnaphylaxisNCT07584863
Virtual Reality-Based Simulation Versus High-Fidelity Simulation for Emergency Management Training in Medical Interns
A study testing Virtual Reality-Based Emergency Simulation and High-Fidelity Simulation in people with Anaphylaxis and Hypoxia, run by Seoul National University Hospital at 1 site in South Korea.
Trial summary
This study is a two-arm parallel randomized controlled non-inferiority trial designed to compare the educational effectiveness of virtual reality (VR)-based simulation with high-fidelity simulation (HFS) for emergency management training in medical interns. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Anaphylaxis, Hypoxia
- What is being tested?
- Virtual Reality-Based Emergency Simulation and High-Fidelity Simulation
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 124 participants
- Where
- 1 siteSouth Korea
- Study dates
- 20 Feb 2026to 31 Dec 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Medical interns enrolled in the 2026 internship program at Seoul National University Hospital
- Provided written informed consent
Who cannot join
- Did not complete pre-training survey
- Declined participation
Trial locations and contacts
1 site in 1 country.
About this study
Official title: A Randomized Controlled Study Comparing Virtual Reality-Based Simulation With High-fidelity Simulation for Training Novice Physicians in Emergency Management
This study is a two-arm parallel randomized controlled non-inferiority trial designed to compare the educational effectiveness of virtual reality (VR)-based simulation with high-fidelity simulation (HFS) for emergency management training in medical interns.
Participants will be randomized 1:1 to either VR-based training or HFS-based training for managing desaturation and anaphylaxis scenarios. After training and structured debriefing, all participants will undergo objective structured clinical examinations (OSCEs) and complete pre- and post-training surveys.
The primary outcome is OSCE performance score. Secondary outcomes include confidence improvement, participant satisfaction, usability (UEQ-S).
- Conditions
- Anaphylaxis, Hypoxia
- Being tested
- Virtual Reality-Based Emergency Simulation, High-Fidelity Simulation
- Keywords
- Virtual Reality, High-Fidelity Simulation, Medical Education, OSCE, Emergency Training, Anaphylaxis, Desaturation, Simulation-Based Education
- Medical subject headings
- Anaphylaxis, Hypoxia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Virtual Reality-Based Emergency SimulationBehavioural
Participants use an immersive VR platform to manage simulated patients with oxygen desaturation and anaphylaxis.
High-Fidelity SimulationBehavioural
Participants use a high-fidelity simulator (Sim-Man) to manage the same emergency scenarios.
| Study group | Role | What they receive |
|---|---|---|
| VR Group | Experimental | Participants use an immersive VR platform to manage simulated patients with oxygen desaturation and anaphylaxis. Receives: Behavioral: Virtual Reality-Based Emergency Simulation |
| HFS Group | Active comparator | Participants use a high-fidelity simulator (Sim-Man) to manage the same emergency scenarios. Receives: Behavioral: High-Fidelity Simulation |
What is being measured
The primary outcome is the main question the study is designed to answer.
OSCE Performance Score
Mean total score of two Objective Structured Clinical Examination (OSCE) stations (desaturation and anaphylaxis). Scores range from 0 to 20, with higher scores indicating better clinical performance.
Measured: Immediately after training
Secondary outcomes (3)
Confidence Improvement
Self-reported confidence in emergency management measured using a 10-point Likert scale ranging from 1 to 10, with higher scores indicating greater confidence.
Measured: Immediately before and immediately after training
Participant Satisfaction
Participant satisfaction measured using a 7-point Likert scale ranging from 1 to 7, with higher scores indicating greater satisfaction.
Measured: Immediately after training
Usability (UEQ-S)
Usability assessed using the User Experience Questionnaire-Short Version (UEQ-S). Scores range from 1 to 7, with higher scores indicating a more positive user experience.
Measured: Immediately after training
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 May 2026
- Study start20 Feb 2026
- Primary completion31 Dec 2027 (estimated)
- Study completion31 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AnaphylaxisStudies of the same condition, open and under way.
- More trials run by Seoul National University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Study Type: Interventional//Medical Education and Training
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 124 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Seoul National University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sun Jung Myung, Seoul National University Hospital
- Investigators
- Sun Jung Myung, Principal investigator, Seoul National University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07584863
- Sponsor's protocol ID
- C-2602-161-1723
- Status last verified
- Feb 2026
- First submitted
- 20 Apr 2026
- Last updated
- 13 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Randomized Controlled Study Comparing Virtual Reality-Based Simulation With High-fidelity Simulation for Training Novice Physicians in Emergency Management
- ClinicalTrials.gov ID
- NCT07584863
- Acronym / sponsor ID
- C-2602-161-1723
- Conditions
- Anaphylaxis, Hypoxia
- Keywords
- Virtual Reality, High-Fidelity Simulation, Medical Education, OSCE, Emergency Training, Anaphylaxis, Desaturation, Simulation-Based Education
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 124 participants (estimated)
- Lead sponsor
- Seoul National University HospitalUniversity, hospital or other
- Study start
- 20 Feb 2026 (actual)
- Primary completion
- 31 Dec 2027 (estimated)
- Study completion
- 31 Dec 2027 (estimated)
- First posted
- 13 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is a two-arm parallel randomized controlled non-inferiority trial designed to compare the educational effectiveness of virtual reality (VR)-based simulation with high-fidelity simulation (HFS) for emergency management training in medical interns.
Participants will be randomized 1:1 to either VR-based training or HFS-based training for managing desaturation and anaphylaxis scenarios. After training and structured debriefing, all participants will undergo objective structured clinical examinations (OSCEs) and complete pre- and post-training surveys.
The primary outcome is OSCE performance score. Secondary outcomes include confidence improvement, participant satisfaction, usability (UEQ-S).
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Study Type: Interventional//Medical Education and Training
| Arm | Type | Receives |
|---|---|---|
| VR Group | Experimental | Behavioral: Virtual Reality-Based Emergency SimulationParticipants use an immersive VR platform to manage simulated patients with oxygen desaturation and anaphylaxis. |
| HFS Group | Active comparator | Behavioral: High-Fidelity SimulationParticipants use a high-fidelity simulator (Sim-Man) to manage the same emergency scenarios. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (2 listed)
- Medical interns enrolled in the 2026 internship program at Seoul National University Hospital
- Provided written informed consent
Key exclusion criteria (2 listed)
- Did not complete pre-training survey
- Declined participation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Virtual Reality-Based Emergency SimulationParticipants use an immersive VR platform to manage simulated patients with oxygen desaturation and anaphylaxis. | Behavioural | VR Group |
| High-Fidelity SimulationParticipants use a high-fidelity simulator (Sim-Man) to manage the same emergency scenarios. | Behavioural | HFS Group |
Primary outcome
OSCE Performance Score
Time frame: Immediately after training
Mean total score of two Objective Structured Clinical Examination (OSCE) stations (desaturation and anaphylaxis). Scores range from 0 to 20, with higher scores indicating better clinical performance.
3 secondary outcomes
Confidence Improvement
Time frame: Immediately before and immediately after training
Participant Satisfaction
Time frame: Immediately after training
Usability (UEQ-S)
Time frame: Immediately after training
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 May 2026.
Related trials for Anaphylaxis
Not yet recruitingPhase 2
Pharmacokinetics and Safety of a Single Dose of Epinephrine Nasal Spray in Paediatric Allergy Patients
Epinephrine, Hypersensitivity, Immediate
Active, not recruitingObservational study
EPAP, Interviewstudy
Food Allergy, Food Allergy Peanut
RecruitingObservational study
Post-market Safety Study of LUMISIGHT
Hypersensitivity Reactions
Active, not recruitingObservational study
Mechanisms of Anaphylaxis
Anaphylaxis, Allergy
RecruitingPhase 1/2
UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies
Peanut-Induced Anaphylaxis, Peanut Allergy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sun Jung Myung principal investigator
Seoul National University Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Virtual Reality-Based Emergency Simulation and High-Fidelity Simulation in people with Anaphylaxis and Hypoxia, run by Seoul National University Hospital at 1 site in South Korea.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 13 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
OSCE Performance Score (time frame: Immediately after training). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2026.